Full-Time

Clinical Trial Manager-Early Phase exp req'd

Posted on 11/23/2024

Neurocrine Biosciences

Neurocrine Biosciences

1,001-5,000 employees

Biotechnology
Healthcare

Compensation Overview

$125.7k - $182.3kAnnually

+ Annual Bonus + Equity Incentive Program

Mid, Senior

San Diego, CA, USA

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Data Analysis
Google Cloud Platform
Requirements
  • BS/BA degree and 8+ years of clinical trial management experience, including CRO/vendor management (domestic and international), monitoring of budget scope, clinical site monitoring or related experience required OR
  • Master’s and 6+ years of related experience
  • Prior Phase 1 trial management experience. Preferred at Sponsor level that managed directly under in house SOPs vs. outsourced to a CRO
  • Flexible, adaptable, strong team communication
  • Both US and Ex US study management (experience with IND and CTA submissions)
  • Vendor management experience
  • Must have detailed knowledge of clinical drug development process including working knowledge of ICH, Good Clinical Practices (GCPs), FDA regulations, and EU Directive
  • Excellent knowledge of clinical operations, specifically conducting clinical studies from start-up through close-out.
  • Broad trial management protocol and process knowledge
  • Strong understanding of Clinical Research industry and the relevant environments in which it operates
  • Ability to identify and organize clinical resources needed to accomplish tasks, set objectives and provide clear direction to others; experience planning activities in advance and taking account of possible changing circumstances; manages time effectively
  • Has knowledge of best practices in the functional discipline and familiarity with the broader underlying concepts of related business disciplines
  • Works to improve tools and processes within functional area
  • Developing reputation inside the company as it relates to area of expertise
  • Ability to work as part of and lead multiple teams
  • Exhibits leadership skill and ability, typically leads lower levels and/or indirect teams
  • Excellent computer skills
  • Excellent communications, problem-solving, analytical thinking skills
  • Sees broader picture, impact on multiple departments/divisions
  • Ability to meet multiple deadlines across a variety of projects/programs, with a high degree of accuracy and efficiency
  • Excellent project management skills
  • Proven ability to work through others to deliver results to the appropriate quality and timeline metrics, monitoring/managing performance and providing feedback; experience productively partnering cross functionally and with customers to advance work effectively and efficiently
  • Proven ability at analyzing data and information to derive conclusions and drive sound decision making
Responsibilities
  • Ensures clinical studies are conducted in compliance with Food and Drug Administration (FDA) regulations, EU Directive, International Conference on Harmonization (ICH) guidelines, and NBI Standard Operating Procedures (SOPs) and policies
  • Serves as primary point of contact for clinical operations aspects of assigned clinical studies
  • Participates in technical and study design discussions and provides input to clinical trial outlines, protocols, and clinical study reports
  • Manages contract research organizations (CROs) and other contract service providers (CSPs) for assigned studies
  • Leads study team meetings and manages study issues. Develops and manages study timelines in accordance with corporate goals. Identifies barriers to enrollment and develops recruitment solutions
  • Manages internally run studies (without CROs) including the management of CRAs and develops monitoring plans, on-site monitoring guidelines, forms, tools and performs onsite monitoring and co-monitoring visits, as necessary
  • Works collaboratively with clinical operations department in developing, implementing and enforcing NBI standard processes across all clinical programs
  • Other duties as assigned
Neurocrine Biosciences

Neurocrine Biosciences

View

Company Stage

IPO

Total Funding

N/A

Headquarters

San Diego, California

Founded

1992

Growth & Insights
Headcount

6 month growth

0%

1 year growth

0%

2 year growth

0%
Simplify Jobs

Simplify's Take

What believers are saying

  • Positive Phase 2 data for NBI-1117568 in schizophrenia and the launch of INGREZZA SPRINKLE highlight Neurocrine's innovative pipeline and commitment to addressing unmet medical needs.
  • The FDA's acceptance of crinecerfont's New Drug Applications with Priority Review could lead to a significant market breakthrough if approved.
  • Recent investments and executive appointments suggest strong confidence in the company's future growth and strategic direction.

What critics are saying

  • The pharmaceutical industry is highly competitive, and Neurocrine must continuously innovate to maintain its market position.
  • Regulatory hurdles, such as FDA rejections, could delay product launches and impact financial performance.

What makes Neurocrine Biosciences unique

  • Neurocrine Biosciences is pioneering in the treatment of congenital adrenal hyperplasia (CAH) with crinecerfont, a first-in-class therapy that hasn't seen innovation in 70 years.
  • The company offers unique formulations like INGREZZA SPRINKLE, addressing specific patient needs such as dysphagia, which sets them apart in the pharmaceutical landscape.
  • Their focus on rare and serious endocrine disorders, combined with successful clinical trials, positions them as a leader in niche therapeutic areas.

Help us improve and share your feedback! Did you find this helpful?

INACTIVE